Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Worldwide Chemotherapy Drugs Market Outlook to 2023 - Featuring Pfizer, Eli Lilly, Celgene, Bristol-Myers Squibb, Merck & Co, GlaxoSmithKline, Novartis, Sanofi, and Teva Pharmaceutical Industries - ResearchAndMarkets.com By: Research and Markets via Business Wire News Releases April 19, 2019 at 05:28 AM EDT The "Global Chemotherapy Drugs Market: Analysis By Drug Type (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics), By Administration (Oral, Intravenous), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023)" report has been added to ResearchAndMarkets.com's offering. The report analyzes the Chemotherapy Drugs Market for the historical period of 2013-2017 and the forecast period of 2018-2023. According to the report, the market is projected to display a robust growth represented by a CAGR of 11.91% during 2018-2023. On the basis of type of chemotherapy drug, plant alkaloids and antitumor antibiotics have been witnessing growth at a noteworthy rate over the past few years backed by effective use of these medications for the treatment of several varieties of cancers such as breast, ovarian, lung, bladder, prostate, melanoma, esophageal, as well as other types of solid tumors, etc. Amongst the regions, North America accounts for the largest regional share in the global chemotherapy drugs market in 2018. However, in the forecast period, the Asia Pacific region is anticipated to advance at the highest pace. Key factors driving the robust growth rate of Asia Pacific region include boosting production of pharmaceuticals, growing incidence of cancer along with government's focus on medical infrastructural developments. Scope of the Report Global Chemotherapy Drugs Market (Actual Period: 2013-2017, Forecast Period: 2018-2023 Global Chemotherapy Drugs Market - Size, Growth, Forecast By Type of Drug (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics, Others) By Route of Administration (Oral, Intravenous, Others) Regional Markets - North America, Europe, APAC, Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023) Regional Chemotherapy Drugs Market - Size, Growth, Forecast By Type of Drug (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics, Others) By Route of Administration (Oral, Intravenous, Others) Country Analysis - U.S, Canada, United Kingdom, Germany, China and India (Actual Period: 2013-2017, Forecast Period: 2018-2023) Chemotherapy Drugs Market - Size, Growth, Forecast By Type of Drug (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics, Others) By Route of Administration (Oral, Intravenous, Others) Other Report Highlights Market Dynamics - Drivers and Restraints Market Trends SWOT Analysis Porter Five Force Analysis Policy and Regulatory Landscape Company Analysis - Pfizer, Eli Lilly & Company, Celgene Corporation, Bristol-Myers Squibb, Merck & Co., Inc., GlaxoSmithKline plc, Novartis, Sanofi, Teva Pharmaceutical Industries Limited Key Topics Covered1. Research Methodology2. Executive Summary3. Strategic Recommendations4. Chemotherapy Drugs Market Outlook5. Global Chemotherapy Drugs Market: Growth and Forecast 5.1 By Value (2013-2017) 5.2 By Value (2018-2023) 6. Global Chemotherapy Drugs Market: Segment Analysis 6.1 Global Antimetabolite Chemotherapy Drugs Market, By Value (2013-2023) 6.2 Global Plant Alkaloid Chemotherapy Drugs Market, By Value (2013-2023) 6.3 Global Antitumor Antibiotic Chemotherapy Drugs Market, By Value (2013-2023) 6.4 Other Chemotherapy Drugs Market, By Value (2013-2023) 6.5 Global Chemotherapy Drugs Market Size, By Route of Administration: Breakdown (%) 6.5.1 Global Chemotherapy Drugs Market Size, By Route of Administration, 2017 (%) 6.5.2 Global Chemotherapy Drugs Market Size, By Route of Administration, 2023 (%) 6.6 Global Intravenous Chemotherapy Drugs Market, By Value (2013-2023) 6.6 Global Oral Chemotherapy Drugs Market, By Value (2013-2023) 6.7 Other Chemotherapy Drugs Market, By Value (2013-2023) 7. Global Chemotherapy Drugs Market: Regional Analysis 7.1 Global Chemotherapy Drugs Market Size, By Region: Breakdown (%) 7.2 North America Chemotherapy Drugs Market: Growth and Forecast 7.3 North America Chemotherapy Drugs Market: Country Analysis (U.S and Canada) 7.4 Europe Chemotherapy Drugs Market: Growth and Forecast 7.5 Europe Chemotherapy Drugs Market: Country Analysis (Germany and U.K) 7.6 APAC Chemotherapy Drugs Market: Growth and Forecast 7.7 APAC Chemotherapy Drugs Market: Country Analysis (India and China) 7.8 ROW Chemotherapy Drugs Market: Growth and Forecast 8. Global Chemotherapy Drugs Market Dynamics 8.1 Global Chemotherapy Drugs Market Drivers 8.2 Global Chemotherapy Drugs Market Restraints 9. Global Chemotherapy Drugs Market Trends10. Porter Five Force Analysis11. SWOT Analysis12. Policy and Regulatory Landscape14. Company Profiles 14.1 Pfizer 14.2 Eli Lilly & Company 14.3 CELGENE Corporation 14.4 Bristol-Myers Squibb 14.5 Merck & Co. Inc. 14.6 GlaxoSmithKline PLC 14.7 Novartis 14.8 Sanofi 14.9 Teva Pharmaceuticals Industries Limited For more information about this report visit https://www.researchandmarkets.com/r/sgheesView source version on businesswire.com: https://www.businesswire.com/news/home/20190419005042/en/ Contacts: ResearchAndMarkets.comLaura Wood, Senior Press Managerpress@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900Related Topics: Oncology Drugs Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Worldwide Chemotherapy Drugs Market Outlook to 2023 - Featuring Pfizer, Eli Lilly, Celgene, Bristol-Myers Squibb, Merck & Co, GlaxoSmithKline, Novartis, Sanofi, and Teva Pharmaceutical Industries - ResearchAndMarkets.com By: Research and Markets via Business Wire News Releases April 19, 2019 at 05:28 AM EDT The "Global Chemotherapy Drugs Market: Analysis By Drug Type (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics), By Administration (Oral, Intravenous), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023)" report has been added to ResearchAndMarkets.com's offering. The report analyzes the Chemotherapy Drugs Market for the historical period of 2013-2017 and the forecast period of 2018-2023. According to the report, the market is projected to display a robust growth represented by a CAGR of 11.91% during 2018-2023. On the basis of type of chemotherapy drug, plant alkaloids and antitumor antibiotics have been witnessing growth at a noteworthy rate over the past few years backed by effective use of these medications for the treatment of several varieties of cancers such as breast, ovarian, lung, bladder, prostate, melanoma, esophageal, as well as other types of solid tumors, etc. Amongst the regions, North America accounts for the largest regional share in the global chemotherapy drugs market in 2018. However, in the forecast period, the Asia Pacific region is anticipated to advance at the highest pace. Key factors driving the robust growth rate of Asia Pacific region include boosting production of pharmaceuticals, growing incidence of cancer along with government's focus on medical infrastructural developments. Scope of the Report Global Chemotherapy Drugs Market (Actual Period: 2013-2017, Forecast Period: 2018-2023 Global Chemotherapy Drugs Market - Size, Growth, Forecast By Type of Drug (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics, Others) By Route of Administration (Oral, Intravenous, Others) Regional Markets - North America, Europe, APAC, Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023) Regional Chemotherapy Drugs Market - Size, Growth, Forecast By Type of Drug (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics, Others) By Route of Administration (Oral, Intravenous, Others) Country Analysis - U.S, Canada, United Kingdom, Germany, China and India (Actual Period: 2013-2017, Forecast Period: 2018-2023) Chemotherapy Drugs Market - Size, Growth, Forecast By Type of Drug (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics, Others) By Route of Administration (Oral, Intravenous, Others) Other Report Highlights Market Dynamics - Drivers and Restraints Market Trends SWOT Analysis Porter Five Force Analysis Policy and Regulatory Landscape Company Analysis - Pfizer, Eli Lilly & Company, Celgene Corporation, Bristol-Myers Squibb, Merck & Co., Inc., GlaxoSmithKline plc, Novartis, Sanofi, Teva Pharmaceutical Industries Limited Key Topics Covered1. Research Methodology2. Executive Summary3. Strategic Recommendations4. Chemotherapy Drugs Market Outlook5. Global Chemotherapy Drugs Market: Growth and Forecast 5.1 By Value (2013-2017) 5.2 By Value (2018-2023) 6. Global Chemotherapy Drugs Market: Segment Analysis 6.1 Global Antimetabolite Chemotherapy Drugs Market, By Value (2013-2023) 6.2 Global Plant Alkaloid Chemotherapy Drugs Market, By Value (2013-2023) 6.3 Global Antitumor Antibiotic Chemotherapy Drugs Market, By Value (2013-2023) 6.4 Other Chemotherapy Drugs Market, By Value (2013-2023) 6.5 Global Chemotherapy Drugs Market Size, By Route of Administration: Breakdown (%) 6.5.1 Global Chemotherapy Drugs Market Size, By Route of Administration, 2017 (%) 6.5.2 Global Chemotherapy Drugs Market Size, By Route of Administration, 2023 (%) 6.6 Global Intravenous Chemotherapy Drugs Market, By Value (2013-2023) 6.6 Global Oral Chemotherapy Drugs Market, By Value (2013-2023) 6.7 Other Chemotherapy Drugs Market, By Value (2013-2023) 7. Global Chemotherapy Drugs Market: Regional Analysis 7.1 Global Chemotherapy Drugs Market Size, By Region: Breakdown (%) 7.2 North America Chemotherapy Drugs Market: Growth and Forecast 7.3 North America Chemotherapy Drugs Market: Country Analysis (U.S and Canada) 7.4 Europe Chemotherapy Drugs Market: Growth and Forecast 7.5 Europe Chemotherapy Drugs Market: Country Analysis (Germany and U.K) 7.6 APAC Chemotherapy Drugs Market: Growth and Forecast 7.7 APAC Chemotherapy Drugs Market: Country Analysis (India and China) 7.8 ROW Chemotherapy Drugs Market: Growth and Forecast 8. Global Chemotherapy Drugs Market Dynamics 8.1 Global Chemotherapy Drugs Market Drivers 8.2 Global Chemotherapy Drugs Market Restraints 9. Global Chemotherapy Drugs Market Trends10. Porter Five Force Analysis11. SWOT Analysis12. Policy and Regulatory Landscape14. Company Profiles 14.1 Pfizer 14.2 Eli Lilly & Company 14.3 CELGENE Corporation 14.4 Bristol-Myers Squibb 14.5 Merck & Co. Inc. 14.6 GlaxoSmithKline PLC 14.7 Novartis 14.8 Sanofi 14.9 Teva Pharmaceuticals Industries Limited For more information about this report visit https://www.researchandmarkets.com/r/sgheesView source version on businesswire.com: https://www.businesswire.com/news/home/20190419005042/en/ Contacts: ResearchAndMarkets.comLaura Wood, Senior Press Managerpress@researchandmarkets.comFor E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900Related Topics: Oncology Drugs